Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

BioVendor Benefits from Using SCIENION’s Integrated Product Portfolio

Published: Tuesday, July 09, 2013
Last Updated: Tuesday, July 09, 2013
Bookmark and Share
Combined sciDROP PICO and sciDROP NANO technologies used for developing multiplex tests in microtiter plates.

SCIENION AG and BioVendor Laboratorni medicina a.s. have announced that BioVendor is using SCIENION’s complementary product portfolio for the production and detection of immunoassays.

Czech Republic Brno-based BioVendor Laboratorni medicina a.s. produces and distributes medical equipment and medical research products for international markets.

In its Research & Diagnostics Products division, BioVendor focuses on developing and manufacturing in vitro diagnostic and research-use only immunoassays, antibodies and recombinant proteins.

The company has begun developing its immunoassays using SCIENION’s integrated product portfolio including consumables such as sciPLEXPLATES, the sciFLEXARRAYER dispenser configured with both sciPICO and the new sciDROP NANO option, as well as the sciREADER CL for detection of assay results.

Dr. Viktor Růžička, CEO of BioVendor Laboratorni medicina a.s., comments: “Miniaturization and automation are key to our immunoassay production and the sciFLEXARRAYER has proven itself to be a state-of-the-art instrument for precise low volume liquid handling. We use it for developing new multiplex tests in microtiter plates to offer our customers cost-effective tools for parallel analytics. First application examples are multiplex IVD tests for the detection of borrelia infections as borreliosis can become a severe disease if not diagnosed early.”

Růžička also mentions another reason for choosing SCIENION technology: “We are spotting sensitive biological materials such as antigens and antibodies. Temperature is one of the factors that can have an impact of the functionality of these molecules. For us it is an important benefit of the sciFLEXARRAYER that the spotting head does not produce heat - especially as we manufacture tests in large quantities. Furthermore, SCIENION offers a cooling unit for source plates and targets.”

And finally he appreciates that SCIENION provides complete solutions for the automated production and detection of immunoassays because this facilitates work flow and enables advanced performance as products optimally complement each other.

Dr. Holger Eickhoff, CEO of SCIENION AG, states: “BioVendor has become a leading manufacturer of immunoassays for a wide range of applications. The company is known for many innovative products that are unique to the market. We are very pleased that BioVendor has selected SCIENION equipment for assay development and production. From the very start of our collaboration, BioVendor utilizes almost the complete range of our integrated product portfolio. I am confident that this decision will pay off for the company.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos